Free Trial
NASDAQ:IRD

Opus Genetics (IRD) Stock Price, News & Analysis

Opus Genetics logo
$1.07 -0.02 (-1.83%)
Closing price 04:00 PM Eastern
Extended Trading
$1.06 -0.01 (-0.47%)
As of 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Opus Genetics Stock (NASDAQ:IRD)

Key Stats

Today's Range
$1.05
$1.10
50-Day Range
$0.91
$1.22
52-Week Range
$0.65
$1.77
Volume
59,766 shs
Average Volume
558,795 shs
Market Capitalization
$63.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.33
Consensus Rating
Buy

Company Overview

Opus Genetics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
26th Percentile Overall Score

IRD MarketRank™: 

Opus Genetics scored higher than 26% of companies evaluated by MarketBeat, and ranked 818th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Opus Genetics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Opus Genetics has only been the subject of 1 research reports in the past 90 days.

  • Read more about Opus Genetics' stock forecast and price target.
  • Earnings Growth

    Earnings for Opus Genetics are expected to grow in the coming year, from ($1.22) to ($1.03) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Opus Genetics is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Opus Genetics is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Opus Genetics has a P/B Ratio of 5.10. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Opus Genetics' valuation and earnings.
  • Short Interest

    There is no current short interest data available for IRD.
  • Dividend Yield

    Opus Genetics does not currently pay a dividend.

  • Dividend Growth

    Opus Genetics does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for IRD.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Opus Genetics this week, compared to 1 article on an average week.
  • Search Interest

    2 people have searched for IRD on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Opus Genetics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.60% of the stock of Opus Genetics is held by insiders.

  • Percentage Held by Institutions

    Only 14.97% of the stock of Opus Genetics is held by institutions.

  • Read more about Opus Genetics' insider trading history.
Receive IRD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Opus Genetics and its competitors with MarketBeat's FREE daily newsletter.

IRD Stock News Headlines

Amazon’s big Bitcoin embarrassment
Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. While the crowd buys Bitcoin outright, trader Larry Benedict is using a method called “Bitcoin Skimming” to target 6x, 9x, even 22x bigger profits. He reveals how it works in a free video.
See More Headlines

IRD Stock Analysis - Frequently Asked Questions

Opus Genetics' stock was trading at $1.19 at the start of the year. Since then, IRD shares have decreased by 10.1% and is now trading at $1.07.

Opus Genetics, Inc. (NASDAQ:IRD) released its quarterly earnings data on Thursday, May, 15th. The company reported ($0.32) earnings per share for the quarter, beating the consensus estimate of ($0.34) by $0.02. The business had revenue of $4.30 million for the quarter, compared to the consensus estimate of $4 million. Opus Genetics had a negative net margin of 429.42% and a negative trailing twelve-month return on equity of 283.28%.

Shares of IRD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/15/2025
Today
8/08/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IRD
Previous Symbol
NASDAQ:IRD
CIK
1228627
Employees
14
Year Founded
N/A

Price Target and Rating

High Price Target
$8.00
Low Price Target
$6.00
Potential Upside/Downside
+585.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$57.53 million
Net Margins
-429.42%
Pretax Margin
-429.42%
Return on Equity
-283.28%
Return on Assets
-144.32%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.98
Quick Ratio
1.98

Sales & Book Value

Annual Sales
$10.99 million
Price / Sales
5.81
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.21 per share
Price / Book
5.10

Miscellaneous

Outstanding Shares
59,660,000
Free Float
55,723,000
Market Cap
$63.84 million
Optionable
N/A
Beta
0.01
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:IRD) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners